Longevity Health Holdings Inc (XAGE)

$3.30 -0.44 (-11.76%)
Market Cap 2.97M
Revenue (ttm) 50,000.00
Net Income (ttm) -10.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -20,740.00%
Debt to Equity Ratio 0.00
Volume 269,800
Avg Vol 713,747
Day's Range N/A - N/A
Shares Out 1.00M
Stochastic %K 25%
Beta 0.71
Analysts Strong Buy
Price Target N/A

Latest News on XAGE

Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale

May 27, 2025, 9:20 AM EDT - 4 days ago

Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale

Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs

May 21, 2025, 4:30 PM EDT - 10 days ago

Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs

Longevity Health Holdings Announces Business Updates

May 15, 2025, 8:04 AM EDT - 16 days ago

Longevity Health Holdings Announces Business Updates

Longevity Health Holdings, Inc. Announces Reverse Stock Split

May 12, 2025, 8:00 AM EDT - 19 days ago

Longevity Health Holdings, Inc. Announces Reverse Stock Split

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

Mar 10, 2025, 8:30 AM EDT - 2 months ago

CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

Carmell Announces Closing of Elevai Skincare Acquisition

Jan 16, 2025, 8:00 AM EST - 4 months ago

Carmell Announces Closing of Elevai Skincare Acquisition

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Jan 3, 2025, 8:00 AM EST - 5 months ago

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Jan 2, 2025, 8:00 AM EST - 5 months ago

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Dec 24, 2024, 8:30 AM EST - 5 months ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Jul 29, 2024, 8:30 AM EDT - 10 months ago

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Announces Successful Closing of $3.0 Million Private Placement

Apr 11, 2024, 4:30 PM EDT - 1 year ago

Carmell Announces Successful Closing of $3.0 Million Private Placement

Carmell Announces $3.0 Million Private Placement

Apr 4, 2024, 8:30 AM EDT - 1 year ago

Carmell Announces $3.0 Million Private Placement

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

Mar 27, 2024, 9:15 AM EDT - 1 year ago

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Mar 20, 2024, 4:39 PM EDT - 1 year ago

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Mar 18, 2024, 3:16 PM EDT - 1 year ago

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Feb 26, 2024, 8:30 AM EST - 1 year ago

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Nov 16, 2023, 8:30 AM EST - 1 year ago

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

Sep 12, 2023, 12:35 PM EDT - 1 year ago

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

Sep 5, 2023, 6:03 PM EDT - 1 year ago

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

Aug 9, 2023, 3:41 PM EDT - 1 year ago

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

Jul 27, 2023, 7:00 AM EDT - 2 years ago

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Jul 14, 2023, 3:12 PM EDT - 2 years ago

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

Jun 27, 2023, 7:00 AM EDT - 2 years ago

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination